Send to

Choose Destination

See 1 citation found by title matching your search:

JAMA Oncol. 2019 May 1;5(5):607-608. doi: 10.1001/jamaoncol.2019.0093.

US Food and Drug Administration Approval of New Drugs Based on Noninferiority Trials in Oncology: A Dangerous Precedent?

Author information

Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Supplemental Content

Loading ...
Support Center